{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:12:39Z","timestamp":1774991559575,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":371,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jacc.2016.11.044","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T22:01:44Z","timestamp":1485813704000},"page":"538-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mesenchymal Cell Therapy for Dilated\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"69","author":[{"given":"Stefan P.","family":"Janssens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.11.044_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.carpath.2015.02.004","article-title":"The winding road to regenerating the human heart","volume":"24","author":"Gerbin","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacc.2016.11.044_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCRESAHA.115.305227","article-title":"Empowering adult stem cells for myocardial regeneration V2.0: success in small steps","volume":"118","author":"Broughton","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.11.044_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.11.044_bib4","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/CIRCRESAHA.116.305557","article-title":"\u201cString theory\u201d of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results","volume":"116","author":"Keith","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.11.044_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.11.044_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ejhf.434","article-title":"Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design","volume":"18","author":"Bartunek","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2016.11.044_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.044_bib8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2015.09.010","article-title":"Mechanisms contributing to the progression of ischemic and nonischemic dilated cardiomyopathy: possible modulating effects of paracrine activities of stem cells","volume":"66","author":"Kelkar","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.044_bib9","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2013.08.1644","article-title":"The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy","volume":"62","author":"Arbustini","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.044_bib10","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.113.007412","article-title":"Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices","volume":"129","author":"Ascheim","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.11.044_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/eurheartj\/ehv559","article-title":"Improved outcome with repeated intracoronary injection of bone marrow-derived cells within a registry: rationale for the randomized outcome trial REPEAT","volume":"37","author":"Assmus","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716372576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716372576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:24:28Z","timestamp":1536089068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716372576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0735109716372576"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.044","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal Cell Therapy for Dilated\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}